Cencora, Inc. (NYSE: COR) had its price target lowered by analysts at Wells Fargo & Company from $249.00 to $237.00. They now have an "equal weight" rating on the stock.
Cencora Closes $1.8 Billion Senior Notes Offering
Avalere Health welcomes Executive Vice President to fuse policy, access and marketing in a new offering [Yahoo! Finance]
Cencora, Inc. (NYSE: COR) is now covered by analysts at Mizuho. They set an "outperform" rating and a $280.00 price target on the stock.
Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035